Barclays sets USD 10 target for Senseonics Holdings stock
Published on 10/20/2026 at 19:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and reporting date
- Barclays initiated coverage with a USD 10.00 target on October 6, 2026.
- Senseonics reported USD 14.5 million in second-quarter 2026 revenue versus USD 6.6 million a year earlier.
- SENS stock costs EUR 7.35 at Lang & Schwarz on October 20, 2026 at 7:38 p.m. CEST.
- Senseonics raised full-year 2026 revenue guidance to USD 62 million-66 million.
Barclays initiated coverage of Senseonics with an Equal Weight rating and a USD 10.00 price target on October 6, 2026, according to Markets Insider. The target is 21.36 percent above the USD 8.24 Nasdaq price on October 20, 2026. Senseonics stock was trading at EUR 7.35 at Lang & Schwarz on October 20, 2026 at 7:38 p.m. CEST.
Guidance points to scale
Senseonics raised its full-year 2026 global revenue guidance to USD 62 million-66 million from USD 60 million-64 million and lifted gross-margin guidance to 58 percent-61 percent from 55 percent-58 percent, as reported in the second-quarter call transcript by Benzinga on October 12, 2026.
The company generated USD 14.5 million of revenue in the second quarter of 2026 versus USD 6.6 million in the second quarter of 2025. Gross margin was 59 percent, compared with 47 percent a year earlier, while net loss widened to USD 36.7 million from USD 14.5 million.
Stock remains below its yearly high
Senseonics had a USD 4.79 to USD 10.64 52-week range on October 20, 2026. The USD 8.24 Nasdaq quote stood USD 2.40 below the high and USD 3.45 above the low. Market capitalization was USD 435.7 million, while the trading volume was 150,631 shares.
What comes next for results
Investing.com lists November 10, 2026 as Senseonics' next earnings date and identifies the company as a NASDAQ-listed medical technology business, with the SENS ticker and the input ISIN, according to Investing.com. The upcoming report will give investors a new test of the revenue guidance and the margin range.
Comparison with peers
Senseonics: market capitalization USD 435.7 million, gross margin 59 percent. The available company evidence places the main valuation question on execution, because the second-quarter net loss reached USD 36.7 million while revenue was USD 14.5 million.
Investor view
The Barclays target gives the stock a specific valuation marker, while the raised guidance supplies the operating measure behind it. Senseonics' second-quarter revenue of USD 14.5 million and gross margin of 59 percent provide the latest reported baseline for the November 10 results date.
The further course of trading is shown by the continuously updated real-time quote of Senseonics Holdings stock.
Senseonics Holdings market facts
- Company: Senseonics Holdings, Inc.
- ISIN: US81727U3032
- Ticker: SENS
- Primary exchange: NASDAQ
- Price Lang & Schwarz (as of October 20, 2026, 7:38 p.m. CEST): EUR 7.35
- Market capitalization: USD 435.7 million (as of October 20, 2026)
- 52-week range: USD 4.79-10.64 (as of October 20, 2026)
- Sector / Industry: Healthcare / Medical devices
- Next earnings date: November 10, 2026
Market context: Market report S&P 500.
